Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2005 by Therion Biologics Corporation.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Therion Biologics Corporation
ClinicalTrials.gov Identifier:
NCT00078585
First received: March 1, 2004
Last updated: July 7, 2005
Last verified: July 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given